1. Home
  2. NSPR vs GMM Comparison

NSPR vs GMM Comparison

Compare NSPR & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • GMM
  • Stock Information
  • Founded
  • NSPR 2005
  • GMM 2017
  • Country
  • NSPR Israel
  • GMM China
  • Employees
  • NSPR N/A
  • GMM N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • GMM
  • Sector
  • NSPR Health Care
  • GMM
  • Exchange
  • NSPR Nasdaq
  • GMM Nasdaq
  • Market Cap
  • NSPR 75.6M
  • GMM 70.8M
  • IPO Year
  • NSPR N/A
  • GMM 2023
  • Fundamental
  • Price
  • NSPR $2.58
  • GMM $3.23
  • Analyst Decision
  • NSPR Strong Buy
  • GMM
  • Analyst Count
  • NSPR 2
  • GMM 0
  • Target Price
  • NSPR $4.75
  • GMM N/A
  • AVG Volume (30 Days)
  • NSPR 67.4K
  • GMM 33.6K
  • Earning Date
  • NSPR 03-12-2025
  • GMM 05-16-2025
  • Dividend Yield
  • NSPR N/A
  • GMM N/A
  • EPS Growth
  • NSPR N/A
  • GMM 62.17
  • EPS
  • NSPR N/A
  • GMM 6.37
  • Revenue
  • NSPR $7,009,000.00
  • GMM $41,360,953.00
  • Revenue This Year
  • NSPR $50.18
  • GMM N/A
  • Revenue Next Year
  • NSPR $159.56
  • GMM N/A
  • P/E Ratio
  • NSPR N/A
  • GMM $0.61
  • Revenue Growth
  • NSPR 12.96
  • GMM 53.82
  • 52 Week Low
  • NSPR $1.81
  • GMM $0.21
  • 52 Week High
  • NSPR $3.80
  • GMM $4.97
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 39.79
  • GMM 36.14
  • Support Level
  • NSPR $2.57
  • GMM $3.00
  • Resistance Level
  • NSPR $2.78
  • GMM $4.21
  • Average True Range (ATR)
  • NSPR 0.16
  • GMM 0.43
  • MACD
  • NSPR -0.01
  • GMM -0.07
  • Stochastic Oscillator
  • NSPR 31.82
  • GMM 17.71

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.

Share on Social Networks: